Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Lipegfilgrastim in Patients With Non-Small Cell Lung Cancer Receiving Myelosuppressive Therapy
SpringerPlus - Germany
doi 10.1186/s40064-015-1067-7
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 3, 2015
Authors
Publisher
Springer Science and Business Media LLC